Globally conducted clinical trials have shown that semaglutide can provide superior glycemic control and body weight loss compared with placebo, sitagliptin, exenatide extended-release or insulin glargine [13,14,15,16,17,18,19] and compared with additional oral anti-diabetic drugs investigated in a dedicated Japanese trial [20]
Beyond brain health, this supplement also provides benefits for muscle health
Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA
12 Most guidelines recommend SGLT-2 inhibitors as add-on therapy to metformin although monotherapy is potentially appropriate
Yes, most patients continue losing weight at maintenance, though the rate typically slows compared to the dose-escalation phase
Degraded peptides may produce inconsistent or misleading results